Stay updated on Pembrolizumab with Chemo in Ovarian Cancer Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab with Chemo in Ovarian Cancer Clinical Trial page.

Latest updates to the Pembrolizumab with Chemo in Ovarian Cancer Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoNo Change Detected
- Check20 days agoChange DetectedRevision updated from v3.2.0 to v3.3.2 in the page header. No substantive changes to the study details or layout.SummaryDifference0.0%

- Check28 days agoChange DetectedThe government funding notice about potential delays and linking to cc.nih.gov and opm.gov has been removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

- Check42 days agoChange DetectedAdded Ovarian cancer as a related topic and added MedlinePlus Genetics as related topics on the page. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check49 days agoChange DetectedThe page no longer lists the condition 'Ovarian cancer' and the related topic 'MedlinePlus Genetics'.SummaryDifference0.5%

- Check70 days agoChange Detected- Added a government-funding notice about potential delays and updated operating status guidance, and a major version bump to v3.2.0. - Removed the previous version tag v3.1.0.SummaryDifference3%

- Check78 days agoChange DetectedUpdate to revision v3.1.0 and new contact numbers added; removal of a Genetic and Rare Diseases Information Center resource on ovarian cancer (v3.0.2).SummaryDifference0.5%

Stay in the know with updates to Pembrolizumab with Chemo in Ovarian Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab with Chemo in Ovarian Cancer Clinical Trial page.